A MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL TO ASSESS EFFICACY AND SAFETY OF OMECAMTIV MECARBIL IN PATIENTS WITH SYMPTOMATIC HEART FAILURE WITH SEVERELY REDUCED EJECTION FRACTION
Clinical Trial Grant
Awarded By
Cytokinetics, Inc.
Start Date
June 4, 2025
End Date
May 31, 2029
Awarded By
Cytokinetics, Inc.
Start Date
June 4, 2025
End Date
May 31, 2029